
### [MONDO:0017368](http://purl.obolibrary.org/obo/MONDO_0017368)
**Label:** systemic disease with skin involvement

**Subclasses:** [MONDO:0015531](http://purl.obolibrary.org/obo/MONDO_0015531) (non-Langerhans cell histiocytosis), [MONDO:0018768](http://purl.obolibrary.org/obo/MONDO_0018768) (familial cold autoinflammatory syndrome), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (myositis), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0016168](http://purl.obolibrary.org/obo/MONDO_0016168) (Cryopyrin-associated periodic syndrome), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0019340](http://purl.obolibrary.org/obo/MONDO_0019340) (scleroderma (disease)), [MONDO:0007827](http://purl.obolibrary.org/obo/MONDO_0007827) (inclusion body myositis), [MONDO:0017370](http://purl.obolibrary.org/obo/MONDO_0017370) (autoinflammatory syndrome with skin involvement), [MONDO:0009726](http://purl.obolibrary.org/obo/MONDO_0009726) (Proteasome disability syndrome), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0011577](http://purl.obolibrary.org/obo/MONDO_0011577) (myopathy, proximal, and ophthalmoplegia), [MONDO:0017708](http://purl.obolibrary.org/obo/MONDO_0017708) (mevalonate kinase deficiency), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), 

**Corr. equiv. classes:** [OMIM:160750](http://purl.obolibrary.org/obo/OMIM_160750), [Orphanet:324977](http://www.orpha.net/ORDO/Orphanet_324977), [OMIM:605637](http://purl.obolibrary.org/obo/OMIM_605637), [Orphanet:157987](http://www.orpha.net/ORDO/Orphanet_157987), [Orphanet:290842](http://www.orpha.net/ORDO/Orphanet_290842), [Orphanet:90291](http://www.orpha.net/ORDO/Orphanet_90291), [OMIM:605820](http://purl.obolibrary.org/obo/OMIM_605820), [Orphanet:208650](http://www.orpha.net/ORDO/Orphanet_208650), [Orphanet:309025](http://www.orpha.net/ORDO/Orphanet_309025), [Orphanet:47045](http://www.orpha.net/ORDO/Orphanet_47045), [OMIM:147421](http://purl.obolibrary.org/obo/OMIM_147421), [Orphanet:801](http://www.orpha.net/ORDO/Orphanet_801), [Orphanet:646](http://www.orpha.net/ORDO/Orphanet_646), [Orphanet:93672](http://www.orpha.net/ORDO/Orphanet_93672), [Orphanet:602](http://www.orpha.net/ORDO/Orphanet_602), [OMIM:256040](http://purl.obolibrary.org/obo/OMIM_256040), [OMIM:181750](http://purl.obolibrary.org/obo/OMIM_181750), [Orphanet:611](http://www.orpha.net/ORDO/Orphanet_611), 

**Class expressions from DL-Learner:**

- [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 47.60%
- [HP:0002829](http://purl.obolibrary.org/obo/HP_0002829) (Arthralgia) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 47.60%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) 47.60%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) 47.60%
- [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 47.60%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 47.60%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 47.60%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) 47.60%
- [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) 46.16%
- [HP:0003198](http://purl.obolibrary.org/obo/HP_0003198) (Myopathy) and [HP:0004303](http://purl.obolibrary.org/obo/HP_0004303) (Abnormality of muscle fibers) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 46.16%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0002829](http://purl.obolibrary.org/obo/HP_0002829) (Arthralgia) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 46.16%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0002829](http://purl.obolibrary.org/obo/HP_0002829) (Arthralgia) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 46.16%
- [HP:0003326](http://purl.obolibrary.org/obo/HP_0003326) (Myalgia) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) 42.76%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0003326](http://purl.obolibrary.org/obo/HP_0003326) (Myalgia) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) 42.76%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003326](http://purl.obolibrary.org/obo/HP_0003326) (Myalgia) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) 42.76%


